A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease
NCT03913000
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
ID-085
Sponsor
Idorsia Pharmaceuticals Ltd.